Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 5 of 10« First...34567...10...Last »

New senior VP, executive creative director at Biolumina

Diane Iler-Smith returned to Biolumina as senior VP, executive creative director. Iler-Smith has more than 20 years of strategic and creative leadership experience in healthcare communications, including extensive global and US branding and launch expertise. She leads all creative assignments at the agency.

Read More »

Nine promoted at Intouch Solutions

Intouch Solutions continues to elevate employees across the agency.

Read More »

Yes, awards do matter

I recently read an article about how awards do not really matter in the advertising industry. The author basically said the only thing advertising is supposed to do is sell stuff. I agree, but not completely. Awards do matter.

Read More »

The value of leadership

So what is leadership? I believe leadership consists of three components: commitment, integrity, and respect.

Read More »

Government regulations impact prescriber engagement in Ohio

The U.S. regulatory landscape will continue to evolve in 2018, potentially adding complexity and compliance challenges to the life sciences industry. Recent changes are being driven by nationwide concerns with prescription drug abuse, which is prompting many states to enforce new mandates and programs regarding drug practices.

Read More »

Sales & Marketing: Facts and Figures

Two thirds, or 67 percent, of respondents have encountered lower turnover from direct hire sales reps as opposed to CSO reps, according to a recent survey of executives by Best Practices LLC.

Read More »

A multi-channel marketer’s look at integrating EHRs into the digital ecosystem

As the landscape for pharmaceutical marketing continues to evolve, multi-channel marketers have been investigating opportunities to advertise their products and services, and provide clinical decision support information within electronic health records (EHRs). For the first time, healthcare marketers can impact provider-patient interactions by delivering messages directly at the point of care. EHRs have over 90 percent adoption with healthcare professionals (HCPs) in the U.S., while certain practice specialties reach nearly ubiquitous (99 percent) adoption, thereby creating an exceptional opportunity not to be missed!

Read More »

Astellas making leadership changes in Canada and U.S.

Steve Sabus was named general manager of Astellas Pharma Canada (APCA), effective April 1, 2018. In his new role, he will lead business operations in the country.

Read More »

Perrigo appoints Uwe Röhrhoff president and CEO

Uwe Röhrhoff was named CEO of Perrigo Company following the retirement of John T. Hendrickson.

Read More »

Taiho Oncology appoints new president

Timothy Whitten has become president of Taiho Oncology Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co. Ltd. (Japan).

Read More »

New chief medical officer for Neurocrine Biosciences

Christopher O’Brien, M.D., chief medical officer of Neurocrine Biosciences Inc., retired in February 2018 after a transition period with his successor.

Read More »

Agency Exec Shaun Urban Joins Inception Companies

Shaun Urban was named president of the Inception Companies.

Read More »

People on the Move: Specialty Pharma Companies

Wayne Swanton was promoted to executive VP, Global Operations, at Allergan Plc following notification that Rob Stewart, executive VP and chief operating officer, intended to leave Allergan to become president and CEO of Amneal Pharmaceuticals.

Read More »

People on the Move: Biotechnology Companies

Anu Balendran, Ph.D., was appointed VP Business Development at Alligator Bioscience.

Read More »

People on the Move: Service Companies

Michael Mulhern joined AMRI as CEO, succeeding William S. Marth.

Read More »

CVS launches care program to manage cost of RA

CVS Health introduced Transform Rheumatoid Arthritis Care to help the company’s pharmacy benefit management clients better manage care and costs for rheumatoid arthritis. The program is the latest addition to the company’s suite of condition-specific, highly personalized Transform Care programs and adds value-based management strategies including outcomes-based contracts and a new indication-based formulary for autoimmune conditions to CVS Health’s integrated pharmacy care model

Read More »

PBM signs on Jardiance for outcomes-based contract

As part of its CareCentered Contracting program, pharmacy benefit manager Prime Therapeutics LLC entered into an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral type 2 diabetes medicine indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Read More »

FDA Advisory Panel Spurns Pacira’s Request for Expanded Use of Pain Drug Exparel

Shares of Pacira Pharmaceuticals plunged more than 15 percent after the company revealed a U.S. Food and Drug Administration advisory panel recommended against approving expanded use of the company’s pain treatment Exparel.

Read More »

Superstar Investors Jump in on Celgene Spinout Celularity’s $250 Million Funding Round

With a high-profile group of investors and backers, Celgene Corp. spinout Celularity launched with $250 million.

Read More »

Swiss skiers first athletes hit by norovirus at Games

Two Swiss freestyle skiers were the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olympic team confirmed on Friday.

Read More »

Page 5 of 10« First...34567...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom